Low serum HDL-cholesterol concentrations in mid-life predict late-life cognitive impairment in type 2 diabetes: The Fremantle diabetes study.

David G Bruce, Wendy A Davis, Timothy M E Davis

Journal: Journal of diabetes and its complications 2018;31(6):945-947

PMID: 28258907

Full Text on Elsevier Science View on PubMed

Abstract

In a study involving patients with type 2 diabetes assessed annually over 5years, serum HDL-cholesterol was the sole mid-life metabolic predictor of late-life cognitive impairment.

Address: School of Medicine & Pharmacology, University of Western Australia. Electronic address: [email protected].; School of Medicine & Pharmacology, University of Western Australia.

DOI: 10.1016/j.jdiacomp.2016.12.009

Link outs

Free resources

Medical:

https://medlineplus.gov/diabetestype2.html

Other Literature Sources:

https://scite.ai/reports/28258907

Subscription / membership required

Full Text Sources:

MeSH Terms: Age Factors, Age of Onset, Aged, Aged, 80 and over, Cholesterol, HDL, Cognitive Dysfunction, Diabetes Mellitus, Type 2, Female, Humans, Hypoalphalipoproteinemias, Longitudinal Studies, Male, Middle Aged, Prognosis, Risk Factors